How Life Sciences Companies Can Use Electronic Records and eSignatures in the Cloud
The Life Sciences industry is evolving into a more distributed,collaborative and specialized ecosystem where collaboration happens across multiple specialized organizations in order to manufacture, package, perform trials and perform lab work. Information is difficult to exchange electronically especially due to 21 CFR Part 11 concerns about electronic records and electronic signatures. In addition, the industry is moving many software systems into the Cloud adding to the complexity of relying on electronic records and electronic signatures.
View this on-demand webinar to learn about DocuSign’s Digital Transaction Management solution, which is designed to be 21 CFR Part 11 compliant with the help of USDM Life Sciences.
This webinar will include:
- A case study on implementing DocuSign’s Digital Transaction Management solution in the life sciences industry
- A discussion of the Part 11 capabilities of the system
- A discussion on how rapidly this solution can be deployed to alleviate current business compliance bottlenecks.